The Center for Genetic Engineering and Biotechnology (CIGB) ratified today that the drug Nasalferon developed in Cuba against Covid-19 is safe and well tolerated.
The drug, which strengthens the immune system and is administered nasally in a prophylactic scheme with a drop in each nostril twice a day for 10 days, can reduce the risk of severe symptoms in people who contract Covid-19," said a message from the CIGB on the social network Twitter.
This preparation is an antiviral, immunomodulatory and prophylactic product, and it can be used against different acute respiratory diseases.
It is a formulation of recombinant human Alpha-2b-interferon for nasal administration, whose immunomodulatory and antiviral properties prevent the replication of the SARS-CoV-2 coronavirus, which causes the disease, and strengthen the immune system, the text added.
Of proven safety, this preparation had a leading role when the Delta strain of the coronavirus entered the Caribbean country and it was necessary to increase the population's defensive response.